COMPARATIVE ANALYSIS AND CLINICAL VALUE OF THE EXPRESSION OF METALLOPROTEASES AND THEIR INHIBITORS BY INTRATUMOR STROMAL MONONUCLEAR INFLAMMATORY CELLS AND THOSE AT THE INVASIVE FRONT OF BREAST CARCINOMAS

Article English OPEN
Gonzalez , Luis O; Gonzalez-Reyes , Salome; Marin , Laura; Gonzalez , Lucia; Gonzales , José-Manuel; Lamelas , M Luz; Merino , Antonio; Pidal , Ivan; Alvarez , Elena; Andicoechea , Alejandro; Del Casar , José M; Vizoso , Francisco J;
(2010)

International audience; Aims: Matrix metalloproteases (MMPs) and their inhibitors (TIMPs) play an essential role in the degradation of stromal connective tissue and basement membrane components. The dynamic analysis of these components might help predict tumor agressive... View more
  • References (29)
    29 references, page 1 of 3

    Johnson JP, Riethmuller G, Schirrmacher V: Tumor immunology: Paul Ehrlich's heritage. Immunol Today 1989, 10:S35-37.

    Lin EY, Pollard JW: Role of infiltrated leucocytes in tumour growth and spread. Br J Cancer 2004, 90:2053-2058.

    Coussens LM, Werb Z: Inflammation and cancer. Nature 2002, 420:860-867.

    Daniel D, Chiu C, Giraudo E, Inoue M, Mizzen LA, Chu NR, Hanahan D: CD4+ T cell-mediated antigen-specific immunotherapy in a mouse model of cervical cancer. Cancer Res 2005, 65:2018-2025.

    Adams TE, Alpert S, Hanahan D: Non-tolerance and autoantibodies to a transgenic Fself antigen expressed in pancreatic beta cells. Nature 1987, 325:223-228.o Sica A, Bronte V: Altered macrophage differentiation and immune dysfunction in turmor development. J Clin Invest 2007, 117:1155-1166.

    Balkwill F: Cancer and the chemokine network. Nat Rev Cancer 2004, 4:540- 550. P Le Bitoux MA, Stamenkovic I: Tumor-host interactions: the role of inflammation. HistochemeCell Biol 2008, 130:1079-1090.

    e Bingle L, Brown NJ, Lewis CE: The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol 2002, 196:254-265. r Taskinen M, Karjalainen-Lindsberg ML, Leppa S: Prognostic influence of tumor-infiltrating mast cells in pRatients with follicular lymphoma treated with rituximab and CHOP. Blood 2008, 111:4664-4667.

    Nonomura N, Takayama H, Nishimura eK,Oka D, Nakai Y, Shiba M, Tsujimura v A, Nakayama M, Aozasa K, Okuyama A: Decreased number of mast cells infiltrating into needle biopsy specimens leads to a better prognosis of prostate cancer. Br J Cancer 2007, 97:952-95i6.

    Novartis Found Symp 2004, 256:158-168; discussion w168-172, 259-169.

    Canevari S, Pupa SM, Menard S: 1975-1995 revised anti-cancer serological response: biological significance and clinical implications. Ann Oncol 1996, 7:227-232.

  • Metrics
Share - Bookmark